 Home > Active Ingredient News > Drugs Articles > GlaxoSmithKline sells two anti-cancer drug concessions for US$342 million

GlaxoSmithKline sells two anti-cancer drug concessions for US$342 million

 Last Update: 2021-04-14
 Source: Internet
 Author: User

Tags

part 2 1990

anti cancer drugs

jobs united states

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

A GSK spokesperson confirmed: "In February 2020, we announced plans to split GSK into two great new companies, which will be funded mainly by asset disposal.

As part of the 2002 collaboration with Exelixis to develop Cabozantinib (the common name for Cabometyx and Cometriq), GSK initially received a 3% royalty.

This move continues Royal's successful strategy of acquiring royalties on pharmaceuticals, diagnostics and medical products.

Legorreta has planned royalty agreements for several famous drugs over the years, including Humira, Truvada, Imbruvica and Trodelvy.

Prior to this, Royalty is obliged to pay 50% of the royalties to the CF Foundation.

In Cabometyx, Royalty has obtained a drug that is expected to become a blockbuster product.

Last year, Cabometyx and Cometriq's sales reached 742 million US dollars and 289 million euros, respectively.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Best price Pure Tirzepatide powder 10mg vial Tirzepatide CAS 2023788-19-2 ouda

CAS No.: 2023788-19-2

Pharmacy Grade

$40.00/G FOB

Safe Delivery Freeze Dried Peptides Raw Powder Weight Loss Tirze Peptide Sema 5mg 10mg

CAS No.: 2023788-19-2

Pharmacy Grade

$120.00/UNIT FOB

RU 58841 CAS 154992-24-2 RU58841 Powder Bulk RU-58841 For Hair Growth and Anti Hair Loss

CAS No.: 154992-24-2

Pharmacy Grade

$1-1.2/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.